This account of the etiology, diagnosis, management and future trends in bladder cancer starts by addressing epidemiological questions, before going on to discuss the molecular factors influencing carcinoma of the bladder. Also covered in Superficial Bladder Cancer are disease and prognosis issues, and new therapies, including biological response modifier, photodynamic treatments and new drugs. The authors aim to address the controversial issues surrounding this topic and provide a consensus of opinion.
This account of the etiology, diagnosis, management and future trends in bladder cancer starts by addressing epidemiological questions, before going on to discuss the molecular factors influencing carcinoma of the bladder. Also covered in <em>Superficial Bladder Cancer </em>are disease and prognosis issues, and new therapies, including biological response modifier, photodynamic treatments and new drugs. The authors aim to address the controversial issues surrounding this topic and provide a consensus of opinion.
Sprache
Verlagsort
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Maße
Höhe: 234 mm
Breite: 159 mm
Gewicht
ISBN-13
978-1-899066-53-7 (9781899066537)
Schlagworte
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Thema Klassifikation
Newbooks Subjects & Qualifier
DNB DDC Sachgruppen
Dewey Decimal Classfication (DDC)
BIC 2 Klassifikation
BISAC Klassifikation
1. Epidemiology of bladder cancer 2. Bladder cancer as a molecular disease 3. Current issues in the pathology of superficial bladder cancer 4. Natural history and prognosis of 'untreated' and 'treated' superficial bladder cancer 5. Prognostic factors: back to the future 6. Towards a better knowledge of bladder cancer 7. Rationale and principles of intravesical therapy 8. Methodology in superficial bladder cancer trials 9. Objective response criteria to intravesical chemotherapy 10. Overview on Doxorubicin and Epirubicin 11. Overview on Mitomycin C (MMC) 12. Overview on Bacillus Calmette-Guerin 13. The use of biological modifiers in the treatment of superficial bladder cancer 14. Intravesical chemotherapy versus immunotherapy 15. Photodynamic therapy of bladder carcinoma 16. Unresponsive superficial bladder cancer 17. Bladder cancer and automated nuclear morphological grading 18. The management of TI bladder tumor: conservative therapy 19. The management of TI tumor: the case for aggressive treatment 20. Carcinoma in situ 21. Follow-up of patients with 'superficial' transitional cell carcinoma of the bladder: time to reflect 22. Satisfaction with life during intravesical immuno-therapy with Bacillus Calmette-Guerin - a pilot study
